194 related articles for article (PubMed ID: 12000992)
1. Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin.
Champney WS; Miller M
Curr Microbiol; 2002 Jun; 44(6):418-24. PubMed ID: 12000992
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for three macrolide antibiotics in Haemophilus influenzae.
Mabe S; Eller J; Champney WS
Curr Microbiol; 2004 Oct; 49(4):248-54. PubMed ID: 15386112
[TBL] [Abstract][Full Text] [Related]
3. Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
Champney WS; Burdine R
Microb Drug Resist; 1998; 4(3):169-74. PubMed ID: 9818968
[TBL] [Abstract][Full Text] [Related]
4. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Champney WS; Tober CL
Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
[TBL] [Abstract][Full Text] [Related]
5. A 50S ribosomal subunit precursor particle is a substrate for the ErmC methyltransferase in Staphylococcus aureus cells.
Champney WS; Chittum HS; Tober CL
Curr Microbiol; 2003 Jun; 46(6):453-60. PubMed ID: 12732954
[TBL] [Abstract][Full Text] [Related]
6. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Burdine R
Curr Microbiol; 1998 Feb; 36(2):119-23. PubMed ID: 9425251
[TBL] [Abstract][Full Text] [Related]
8. Ribosome affinity and the prolonged molecular postantibiotic effect of cethromycin (ABT-773) in Haemophilus influenzae.
Cao Z; Zhong P; Ruan X; Merta P; Capobianco JO; Flamm RK; Nilius AM
Int J Antimicrob Agents; 2004 Oct; 24(4):362-8. PubMed ID: 15380262
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications.
Drew RH; Gallis HA
Pharmacotherapy; 1992; 12(3):161-73. PubMed ID: 1319048
[TBL] [Abstract][Full Text] [Related]
10. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae.
Wang D; Wang Y; Liu YN
Chin Med J (Engl); 2009 Jun; 122(11):1305-10. PubMed ID: 19567142
[TBL] [Abstract][Full Text] [Related]
11. Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.
Destache CJ; Pakiz CB; Kersting K
Pharmacotherapy; 1997; 17(5):985-9. PubMed ID: 9324186
[TBL] [Abstract][Full Text] [Related]
12. Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Miller M
Curr Microbiol; 2002 May; 44(5):350-6. PubMed ID: 11927986
[TBL] [Abstract][Full Text] [Related]
13. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
Halling SM; Jensen AE
BMC Microbiol; 2006 Oct; 6():84. PubMed ID: 17014718
[TBL] [Abstract][Full Text] [Related]
16. The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
Champney WS; Pelt J
Curr Microbiol; 2002 Sep; 45(3):155-60. PubMed ID: 12177734
[TBL] [Abstract][Full Text] [Related]
17. [Azithromycin: critical points].
Philippon A; Cluzel R; Soussy CJ
Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
[TBL] [Abstract][Full Text] [Related]
18. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
Chittum HS; Champney WS
Curr Microbiol; 1995 May; 30(5):273-9. PubMed ID: 7766155
[TBL] [Abstract][Full Text] [Related]
19. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
Hsueh PR; Shyr JM; Wu JJ
Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
[TBL] [Abstract][Full Text] [Related]
20. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
